XML 40 R15.htm IDEA: XBRL DOCUMENT
v3.24.0.1

IMPACT OF THE COVID-19 PANDEMIC | 12 Months Ended
--- | ---
Dec. 31, 2023
Unusual or Infrequent Items, or Both [Abstract] |
Impact of The COVID-19 Pandemic | 3. IMPACT OF THE COVID-19 PANDEMIC The impact of the COVID-19 pandemic had an unprecedented effect on the theatrical exhibition industry. We temporarily closed our theatres in the U.S. and Latin America during March of 2020 at the onset of the COVID-19 outbreak. We reopened theatres as soon as local restrictions and the status of the COVID-19 pandemic would allow. All of our domestic and international theatres were reopened by the end of 2021. After reopening our theatres, we faced ongoing challenges with the significant reduction in the volume of new film releases. The industry has made significant progress in its recovery from the COVID-19 pandemic; however its ongoing recovery continues to be contingent upon several key factors, including the volume of new film content available, which has also been impacted by the recent writers’ and actors’ guild strikes, the box office performance of new film content released, the duration of the exclusive theatrical release window, and evolving consumer behavior with competition from other forms of in-and-out-of-home entertainment. Government Assistance During the years ended December 31, 2021 and 2022, the Company received an aggregate of approximately $2.8 in government assistance pursuant to (i) payroll continuation support programs under the CARES Act, (ii) various grants provided in certain states intended to cover janitorial and personal protection equipment costs incurred by the Company in response to local regulations and (iii) subsidies for certain payroll costs in certain international locations. The Company has met all applicable conditions related to the government assistance received. The government assistance received was reflected as credits to salaries and wages, utilities and other costs, and general and administrative expenses in the consolidated statements of loss. Restructuring Charges In 2020, Company management approved and announced a restructuring plan to realign its operations to create a more efficient cost structure (referred to herein as the “Restructuring Plan”) in response to the COVID-19 pandemic. The Restructuring Plan primarily included a headcount reduction at its domestic corporate office and the permanent closure of certain domestic and international theatres. The following table summarizes activity recorded during the years ended December 31, 2021 and 2022:
|  | U.S. Operating Segment |  |  | International Operating Segment |  |  | Consolidated |
|  | Employee-related Costs |  | Facility Closure Costs |  | Total Charges |  |  | Employee-related Costs |  | Facility Closure Costs |  | Total Charges |  |  | Employee-related Costs |  | Facility Closure Costs |  | Total Charges |
Reserve balance at January 1, 2021 |  | $ | 0.9 |  | $ | 5.7 |  | $ | 6.6 |  |  | $ | — |  | $ | 0.1 |  | $ | 0.1 |  |  | $ | 0.9 |  | $ | 5.8 |  | $ | 6.7 |
Amounts paid |  |  | (0.4 | ) |  | (3.9 | ) |  | (4.3 | ) |  |  | — |  |  | — |  |  | — |  |  |  | (0.4 | ) |  | (3.9 | ) |  | (4.3 | )
Reserve adjustments (1) |  |  | (0.1 | ) |  | (0.9 | ) |  | (1.0 | ) |  |  | — |  |  | — |  |  | — |  |  |  | (0.1 | ) |  | (0.9 | ) |  | (1.0 | )
Reserve balance at December 31, 2021 |  | $ | 0.4 |  | $ | 0.9 |  | $ | 1.3 |  |  | $ | — |  | $ | 0.1 |  | $ | 0.1 |  |  | $ | 0.4 |  | $ | 1.0 |  | $ | 1.4 |
Amounts paid |  |  | (0.4 | ) |  | (0.5 | ) |  | (0.9 | ) |  |  | — |  |  | — |  |  | — |  |  |  | (0.4 | ) |  | (0.5 | ) |  | (0.9 | )
Reserve adjustments (1) |  |  | — |  |  | (0.4 | ) |  | (0.4 | ) |  |  | — |  |  | (0.1 | ) |  | (0.1 | ) |  |  | — |  |  | (0.5 | ) |  | (0.5 | )
Reserve balance at December 31, 2022 |  | $ | — |  | $ | — |  | $ | — |  |  | $ | — |  | $ | — |  | $ | — |  |  | $ | — |  | $ | — |  | $ | — |
Amounts were primarily adjustments based on final facility lease payments for certain closed theatres as compared with original estimates recorded.

X
- References No definition available. + Details
Name: | us-gaap_ExtraordinaryAndUnusualItemsAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for an event or transaction that is unusual in nature or infrequent in occurrence, or both. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Topic 220 -SubTopic 20 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org//220-20/tableOfContent + Details
Name: | us-gaap_UnusualOrInfrequentItemsDisclosureTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration